PMID: 6986134Jan 1, 1980Paper

Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety

Archives of General Psychiatry
M RaskinH V Peeke

Abstract

Recent articles have suggested that muscle biofeedback and transcendental meditation may be useful in treating chronic anxiety. To assess this, we conducted a controlled study comparing muscle biofeedback, transcendental mediation, and relaxation therapy. The study consisted of a six-week baseline period, six weeks of treatment, a six-week posttreatment observation period, and later follow-up. Thirty-one subjects completed the first part of the study and have been followed up for three to 18 months. Forty percent of the subjects had a clinically significant decrease in their anxiety. There were no differences between treatments with respect to treatment efficacy, onset of symptom amelioration, or maintenance of therapeutic gains. We found no evidence suggesting that the degree of muscle relaxation induced by any of the treatments is related to the therapeutic outcome. Relaxation therapies as a sole treatment appear to have a limited place in the treatment of chronic anxiety.

Citations

May 9, 2014·Applied Psychophysiology and Biofeedback·Poppy L A Schoenberg, Anthony S David
Oct 11, 2013·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·David W Orme-Johnson, Vernon A Barnes
Sep 1, 1980·Psychiatry Research·R J MathewJ L Claghorn
Sep 1, 1984·Biofeedback and Self-regulation·C F Sharpley, H J Rogers
Jan 1, 1981·Journal of Psychosomatic Research·R J MathewK M Semchuk
Feb 9, 2007·Expert Review of Neurotherapeutics·Eileen WollburgWalton T Roth
Aug 18, 2012·Psychological Reports·Shirley TellesAcharya Balkrishna
May 13, 2008·Journal of Anxiety Disorders·Michael PluessFrank H Wilhelm
Nov 12, 2009·Journal of Clinical Psychology·Joshua N HookJan P Hook
Nov 1, 1983·Comprehensive Psychiatry·Y LamontagneL Annable
Jan 18, 2003·Sleep Medicine Reviews·Jaime M. Monti, Daniel Monti
Aug 11, 2000·Behaviour Research and Therapy·L G Ost, E Breitholtz
Mar 1, 1995·Journal of Clinical Psychology·N H TrentA P Trent
Mar 18, 2008·Transcultural Psychiatry·Brendan D Kelly
Oct 13, 2006·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Albert J AriasRobert L Trestman
Nov 1, 1983·Journal of Clinical Psychology·D H Shapiro, J Shapiro
Jan 27, 2006·The Cochrane Database of Systematic Reviews·T KrisanaprakornkitM Laopaiboon
Jul 29, 2009·Harvard Review of Psychiatry·Elias Dakwar, Frances R Levin
May 22, 1982·British Medical Journal·G AndrewsD G Byrne
Jul 1, 1994·Acta Psychiatrica Scandinavica·M Z AzharA S Dharap
Mar 1, 1981·Acta Psychiatrica Scandinavica·R J MathewJ L Claghorn
Jan 25, 2020·The Journal of Nervous and Mental Disease·Anna Yusim, Justinas Grigaitis
Oct 1, 1989·The International Journal of Clinical and Experimental Hypnosis·D A SoskisD F Dinges
Apr 1, 2007·Acta Neuropsychiatrica·Belinda Ivanovski, Gin S Malhi
Jul 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·R C Durham, T Allan
Oct 7, 2004·The Medical Journal of Australia·Anthony F JormKelly A Blewitt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.